These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28690035)

  • 21. Influenza A-associated meningoencephalitis.
    Drago L; Attia MW; DePiero A; Bean C
    Pediatr Emerg Care; 2005 Jul; 21(7):437-9. PubMed ID: 16027576
    [No Abstract]   [Full Text] [Related]  

  • 22. HSV-2 meningoencephalitis in an immunocompetent young man: what is the pathogenesis and what is the treatment?
    Fernandez-Gerlinger M; Greffe S; Meffre A; Grenet J; Au S; Bojanova M; Rouveix E; Rozenberg F
    J Clin Virol; 2015 Aug; 69():40-3. PubMed ID: 26209376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laboratory-confirmed influenza B infection in immunized long-term care facility residents receiving oseltamivir prophylaxis in Ontario.
    Winter AL; Peci A; Eshaghi A; Baird M; Memari N; Kristjanson E; Balogun E; Higgins RR; Li A; Farrell DJ; Gubbay JB
    Infect Control Hosp Epidemiol; 2013 Nov; 34(11):1225-8. PubMed ID: 24113612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virus load kinetics and resistance development during oseltamivir treatment in infants and children infected with Influenza A(H1N1) 2009 and Influenza B viruses.
    Rath B; von Kleist M; Tief F; Karsch K; Tuerk E; Muehlhans S; Louis F; Skopnik H; Schweiger B; Duwe S
    Pediatr Infect Dis J; 2012 Sep; 31(9):899-905. PubMed ID: 22581220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.
    Sugaya N; Tamura D; Yamazaki M; Ichikawa M; Kawakami C; Kawaoka Y; Mitamura K
    Clin Infect Dis; 2008 Aug; 47(3):339-45. PubMed ID: 18582202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety, virology and pharmacokinetics of oseltamivir in infants with laboratory-confirmed influenza: a Phase I/II, prospective, open-label, multicentre clinical trial.
    Rath BA; Brzostek J; Guillén S; Niranjan V; Chappey C; Rayner CR; Clinch B
    Antivir Ther; 2015; 20(8):815-25. PubMed ID: 26015411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children.
    Sugaya N; Mitamura K; Yamazaki M; Tamura D; Ichikawa M; Kimura K; Kawakami C; Kiso M; Ito M; Hatakeyama S; Kawaoka Y
    Clin Infect Dis; 2007 Jan; 44(2):197-202. PubMed ID: 17173216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cluster of patients infected with I221V influenza b virus variants with reduced oseltamivir susceptibility--North Carolina and South Carolina, 2010-2011.
    Garg S; Moore Z; Lee N; McKenna J; Bishop A; Fleischauer A; Springs CB; Nguyen HT; Sheu TG; Sleeman K; Finelli L; Gubareva L; Fry AM
    J Infect Dis; 2013 Mar; 207(6):966-73. PubMed ID: 23242536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial.
    Watanabe A; Chang SC; Kim MJ; Chu DW; Ohashi Y;
    Clin Infect Dis; 2010 Nov; 51(10):1167-75. PubMed ID: 20936975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season.
    Kawai N; Ikematsu H; Iwaki N; Satoh I; Kawashima T; Maeda T; Miyachi K; Hirotsu N; Shigematsu T; Kashiwagi S
    Clin Infect Dis; 2005 May; 40(9):1309-16. PubMed ID: 15825034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Encephalopathy and influenza virus].
    Tardy N; El Zeenni N; Rogeaux O; Vercueil L; Forestier E
    Med Mal Infect; 2016 Dec; 46(8):442-444. PubMed ID: 27692826
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral oseltamivir in human experimental influenza B infection.
    Hayden FG; Jennings L; Robson R; Schiff G; Jackson H; Rana B; McClelland G; Ipe D; Roberts N; Ward P
    Antivir Ther; 2000 Sep; 5(3):205-13. PubMed ID: 11075941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice.
    Vogel GE
    Med Microbiol Immunol; 2002 Dec; 191(3-4):161-3. PubMed ID: 12458352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Parechovirus meningoencephalitis without CSF pleocytosis].
    Mansachs SJ; Stanchev H
    Ugeskr Laeger; 2014 Mar; 176(11B):. PubMed ID: 25350811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of anti-influenza virus activity and pharmacokinetics of oseltamivir free base and oseltamivir phosphate.
    Shin JS; Ku KB; Jang Y; Yoon YS; Shin D; Kwon OS; Go YY; Kim SS; Bae MA; Kim M
    J Microbiol; 2017 Dec; 55(12):979-983. PubMed ID: 29214495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of the clinical effectiveness of the neuraminidase inhibitors against influenza B viruses.
    Farrukee R; Mosse J; Hurt AC
    Expert Rev Anti Infect Ther; 2013 Nov; 11(11):1135-45. PubMed ID: 24093683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of Oral and Intravenous Oseltamivir Treatment of Severe Influenza B Virus Infection Requiring Organ Replacement Therapy.
    Karsch K; Chen X; Miera O; Peters B; Obermeier P; Francis RC; Amann V; Duwe S; Fraaij P; Heider A; de Zwart M; Berger F; Osterhaus A; Schweiger B; Rath B
    Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):155-164. PubMed ID: 26994602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neuraminidase inhibitor].
    Kaji M
    Nihon Rinsho; 2000 Nov; 58(11):2293-8. PubMed ID: 11225320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1,2,3-Triazolyl-4-oxoquinolines: A feasible beginning for promising chemical structures to inhibit oseltamivir-resistant influenza A and B viruses.
    Boechat Fda C; Sacramento CQ; Cunha AC; Sagrillo FS; Nogueira CM; Fintelman-Rodrigues N; Santos-Filho O; Riscado CS; Forezi Lda S; Faro LV; Brozeguini L; Marques IP; Ferreira VF; Souza TM; de Souza MC
    Bioorg Med Chem; 2015 Dec; 23(24):7777-84. PubMed ID: 26643220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Encephalitis and meningoencephalitis in patients with influenza].
    Vashchenko MA; Trinus EK; Iatel' TP; Rudenko AA; Radkevich TA
    Vrach Delo; 1974 Jan; (1):132-6. PubMed ID: 4468562
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.